Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis.
Conceição M, Shteinberg M, Goeminne P, Altenburg J, Chalmers JD.
Eur Respir Rev. 2024 Jan 31;33(171):230178. doi: 10.1183/16000617.0178-2023. Print 2024 Jan 31.
A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection.
Guan WJ, Xu JF, Luo H, Xu XX, Song YL, Ma WL, Liang ZA, Liu XD, Zhang GJ, Zhang XJ, Li RK, Zhu SY, Zhang YJ, Cai XJ, Wei LP, Tian DB, Zhao H, Chen PY, Qu JM, Zhong NS; TORNASOL Study Group.
Chest. 2023 Jan;163(1):64-76. doi: 10.1016/j.chest.2022.07.007. Epub 2022 Jul 19.
Infection and the microbiome in bronchiectasis.
Mac Aogáin M, Dicker AJ, Mertsch P, Chotirmall SH.
Eur Respir Rev. 2024 Jul 3;33(173):240038. doi: 10.1183/16000617.0038-2024. Print 2024 Jul.
Bronchiectasis.
Barbosa M, Chalmers JD.
Presse Med. 2023 Sep;52(3):104174. doi: 10.1016/j.lpm.2023.104174. Epub 2023 Sep 30.
Bronchiectasis and inhaled tobramycin: A literature review.
Elborn JS, Blasi F, Haworth CS, Ballmann M, Tiddens HAWM, Murris-Espin M, Chalmers JD, Cantin AM.
Respir Med. 2022 Feb;192:106728. doi: 10.1016/j.rmed.2021.106728. Epub 2022 Jan 1.
Endotypes of Pseudomonas aeruginosa Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4).
Hull RC, Stobo J, Abo-Leyah H, Richardson H, Alferes de Lima Headley D, Long MB, Hennayake C, Gilmour A, Johnson ED, Tunney M, Dicker AJ, Kewin E, Huang JTJ, Haworth CS, Chalmers JD.
Am J Respir Crit Care Med. 2025 Aug;211(8):1397-1408. doi: 10.1164/rccm.202501-0159OC.
Phenotypical characteristics of nontuberculous mycobacterial infection in patients with bronchiectasis.
Frajman A, Izhakian S, Mekiten O, Hadar O, Lichtenstadt A, Hajaj C, Shchori S, Heching M, Rosengarten D, Kramer MR.
Respir Res. 2024 Jul 15;25(1):278. doi: 10.1186/s12931-024-02904-0.
Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
Sangiovanni S, Morales EI, Fernández-Trujillo L.
Respir Med. 2021 Jan;176:106283. doi: 10.1016/j.rmed.2020.106283. Epub 2020 Dec 5.
Radiologic Characteristics of Non-tuberculous Mycobacteria Infection in Patients with Bronchiectasis.
Eisenberg I, Yasin A, Fuks L, Stein N, Saliba W, Kramer MR, Adir Y, Shteinberg M.
Lung. 2020 Aug;198(4):715-722. doi: 10.1007/s00408-020-00371-0. Epub 2020 Jun 26.
Association of low fat mass with nontuberculous mycobacterial infection in patients with bronchiectasis.
Lim SY, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH.
Medicine (Baltimore). 2021 Apr 9;100(14):e25193. doi: 10.1097/MD.0000000000025193.
